Scryber launches AI platform for neurology practices
Scryber has launched an AI documentation and revenue intelligence platform built specifically for neurology practices. The Boca Raton startup says the tool is designed to reduce note-taking burden and give physicians clearer visibility into claims, payments and practice revenue.
Why it matters: - Neurology practices often face heavy documentation demands and complex billing workflows. - Scryber is aimed at reducing after-hours note work while helping practices track revenue from visit to payment. - The platform targets independent and group neurology practices with 1 to 15 providers.
What happened: - Scryber launched its platform at scryber.ai. - The company was co-founded by Dr. Patricio Espinosa, a Harvard-trained neurologist, and Jill Willard, a fintech technology executive. - The launch took place Nov. 2, 2026, in Boca Raton, Florida.
The details: - Scryber includes two launch modules: Transcryber and Visualyzer. - Transcryber provides real-time AI transcription and generates neurology-specific SOAP notes with CPT and ICD-10 code suggestions. - Visualyzer provides a revenue intelligence dashboard with payment reconciliation, AR aging, payer mix and infusion margin tracking. - Visualyzer also includes a Coding Reviewer that checks for coding mistakes and flags missed billing opportunities. - A third module, Optimyzer, is planned for December 2026. - Scryber is priced at $85 per user per month. - The subscription includes a 60-day free trial, unlimited transcriptions, no tiers and no per-encounter fees. - Scryber supports HIPAA-compliant workflows, and a Business Associate Agreement is available. - The platform supports English and Spanish. - Notes can be copied and pasted into any EHR without a new EHR implementation.
Between the lines: - Scryber is positioning itself as more than an AI scribe by tying documentation directly to revenue management. - The founders are leaning on both clinical and financial expertise to differentiate the product from general-purpose medical AI tools. - The company is making a narrow specialty focus a selling point, which may appeal to practices that want workflow tools tailored to neurology rather than broad clinical automation. - Dr. Espinosa said the product was built to give neurologists more time with patients and clearer visibility into revenue. - Willard said the platform was built to connect documentation and revenue so practices can see where money is going.
What's next: - Scryber plans to release Optimyzer in December 2026. - Practices can start a free trial or request a demo at scryber.ai. - The company is also directing users to its social channels for updates, including LinkedIn, Facebook, YouTube and TikTok.
The bottom line: - Scryber is betting that specialty-specific AI plus revenue intelligence will resonate with neurology practices looking to save time and tighten billing oversight.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Modern Finance Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.